The DOI matches its Crossref record; 471 of the 471 references it cites were found in a registry or an index.
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Open accessAbstract
national Society for Heart and Lung Transplantation; d Representing the European League Against Rheumatism; and e Representing the European Society of Radiology.ESC entities having participated in the development of this document: ESC Associations: Acute Cardiovascular Care Association (ACCA), European Association for Cardiovascular Prevention & Rehabilitation (EACPR), European Association of Cardiovascular Imaging (EACVI), European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Heart Rhythm Association (EHRA), Heart Failure Association (HFA).ESC Councils: Council for Cardiology Practice (CCP), Council on Cardiovascular Nursing and Allied Professions (CCNAP), Council on Cardiovascular Primary Care (CCPC).ESC Working Groups: Cardiovascular Pharmacotherapy, Cardiovascular Surgery, Grown-up Congenital Heart Disease, Pulmonary Circulation and Right Ventricular Function, Valvular Heart Disease.The content of these European Society of Cardiology (ESC) and European Respiratory Society (ERS) Guidelines has been published for personal and educational use only.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In the World Symposium of Pulmonary Hypertension classification of PAH, group 1 is the most common indication.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [61]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The ESC/ERS model also employs the assessment of risk using a multi-parametric comprehensive analysis of clinical variables.(284) Unlike REVEAL, this model avoids use of any non-modifiable criteria, and does not “weight” the variables according to their relative importance.”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [284]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Unlike REVEAL, this model avoids use of any non-modifiable criteria, and does not “weight” the variables according to their relative importance.”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [284]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“transplantation may be necessary if prostacyclin treatment is required for an appropriate intervention, there is accompanying liver or renal failure, or severe hemoptysis is present [3,59-62]”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“group 3 with PAH and accompanying pathological changes in the lung parenchyma can be considered for transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [61]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Group 2, with decreased left ventricular function, is not an indication for transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [61]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The two most frequently used risk assessment models are the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management (REVEAL) 2.0 and the 2015 European Society of Cardiology/European Respiratory Society (ESC/ERS) model.(283, 284)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [284]
The cited source says what the claim attributes to it.
In the citing paper
“The ESC/ERS model also employs the assessment of risk using a multi-parametric comprehensive analysis of clinical variables.(284)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [284]
The cited source says what the claim attributes to it.
In the citing paper
“The current consensus is based on 2 tools for referral and listing: the REVEAL Registry 2.2 (Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management 2.0) and 2015 European Society of Cardiology/European Respiratory Society.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 20,604
Self-citationLang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., Flachskampf, F. A., Foster, E., Goldstein, S. A., Kuznetsova, T., et al. (2015) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.10.003 · Cited by 12,362
Self-citationLang, R. M., Badano, L. P., Mor‐Avi, V., Afilalo, J., Armstrong, A. D. C., Ernande, L., Flachskampf, F. A., Foster, E., Goldstein, S. A., Kuznetsova, T., et al. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jev014 · Cited by 8,630
Self-citationRudski, L., Lai, W. W., Afilalo, J., Hua, L., Handschumacher, M. D., Chandrasekaran, K., Solomon, S. D., Louie, E. K., & Schiller, N. B. (2010) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2010.05.010 · Cited by 7,080
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
Self-citationInterpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationGuidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Hoeper, M. M., Humbert, M. J. C., Torbicki, A., Vachiéry, J., Barberà, J. A., Beghetti, M., Corris, P. A., Gaine, S., Gibbs, J. S. R., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,853
Self-citationGuidelines on the management of valvular heart disease
Vahanian, A. S., Baumgartner, H., Bax, J. J., Butchart, E., Dion, R., Filippatos, G. S., Flachskampf, F., Hall, R., Iung, B., Kasprzak, J. D., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl428 · Cited by 3,579
Self-citationGuidelines on the management of valvular heart disease (version 2012)
Authors/Task Force Members, Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M. J., Barón-Esquivias, G., Baumgartner, H., Borger, M. A., Carrel, T. P., De Bonis, M., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs109 · Cited by 3,559
Self-citationBosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., KEOGH, A. M., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,718
Self-citationBarst, R. J., Rubin, L. J., Long, W. A., McGoon, M. D., Rich, S., Badesch, D. B., Groves, B. Μ., Tapson, V. F., Bourge, R. C., Brundage, B. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340504 · Cited by 2,688
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D. B., Fleming, T. R., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,466
Self-citationUpdated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S., Gladwin, M. T., Jing, Z., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,129
Self-citationPrimary Pulmonary Hypertension
Rich, S., DANTZKER, D. R., AYRES, S. M., BERGOFSKY, E. H., BRUNDAGE, B. H., Detre, K. M., FISHMAN, A. P., GOLDRING, R. M., GROVES, B. M., KOERNER, S. K., et al. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-216 · Cited by 2,027
Pulmonary Arterial Hypertension in France
Humbert, M. J. C., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaïci, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1668oc · Cited by 1,994
Self-citationClinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G. M., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,895
Self-citationExpression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
Giaid, A., Yanagisawa, M., Langleben, D., Michel, R. P., Levy, R. D., Shennib, H., Kimura, S., Masaki, Τ., Duguid, W. P., & Stewart, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282402 · Cited by 1,838
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
Pengo, V., Lensing, A. W. A., Prins, M. H., Marchiori, A., Davidson, B. L., Tiozzo, F., Albanese, P., Biasiolo, A., Pegoraro, C., Iliceto, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032274 · Cited by 1,828
Inhaled Iloprost for Severe Pulmonary Hypertension
Olschewski, H., Simonneau, G., Galiè, N., HIGENBOTTAM, T. W., Naeije, R., Rubin, L. J., Nikkho, S. M., Speich, R., Hoeper, M. M., Behr, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020204 · Cited by 1,784
Self-citationDefinitions and Diagnosis of Pulmonary Hypertension
Hoeper, M. M., Bogaard, H. J., Condliffe, R., Frantz, R. P., Khanna, D., Kurzyna, M., Langleben, D., Manes, A., Satoh, T., Torres, F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.032 · Cited by 1,763
Self-citationAbraham, W. T., Adamson, P. B., Bourge, R. C., Aaron, M. F., Costanzo, M. R., Stevenson, L. W., Strickland, W., Neelagaru, S., Raval, N., Krueger, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60101-3 · Cited by 1,744
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,558
Benza, R. L., Miller, D. P., Gomberg-Maitland, M., Frantz, R. P., Foreman, A. J., Coffey, C. S., Frost, A., Barst, R. J., Badesch, D. B., Elliott, C. G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.898122 · Cited by 1,547
Channick, R. N., Simonneau, G., Sitbon, O., Robbins, I. M., Frost, A., Tapson, V. F., Badesch, D. B., Roux, S., Rainisio, M., Bodin, F., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06250-x · Cited by 1,529
Self-citationSimonneau, G., Barst, R. J., Galiè, N., Naeije, R., Rich, S., Bourge, R. C., KEOGH, A. M., Oudiz, R. J., Frost, A., Blackburn, S. D., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.6.2106079 · Cited by 1,440
Self-citationMacitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
Pulido, T., Адзерихо, И. Э., Channick, R. N., Delcroix, M., Galiè, N., Ghofrani, H. A., Jansa, P., Jing, Z., Brun, F. L., Mehta, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213917 · Cited by 1,439
Self-citationRiociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
Ghofrani, H. A., D’Armini, A. M., Grimminger, F., Hoeper, M. M., Jansa, P., Kim, N. H., Mayer, E., Simonneau, G., Wilkins, M. R., Fritsch, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209657 · Cited by 1,393
Self-citationLong-term intravenous epoprostenol infusion in primary pulmonary hypertension
Sitbon, O., Humbert, M. J. C., Nunès, H., Parent, F., Garcia, G., Hervé, P., Rainisio, M., & Simonneau, G. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02012-0 · Cited by 1,374
Self-citationGiaid, A., & Saleh, D. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330403 · Cited by 1,366
Riociguat for the treatment of pulmonary arterial hypertension
Ghofrani, H.-A., Galiè, N., Grimminger, F., Grünig, E., Humbert, M., Jing, Z.-C., Keogh, A. M., Langleben, D., Kilama, M. O., Fritsch, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209655 · Cited by 1,346
Self-citationGhio, S., Gavazzi, A., Campana, C., Inserra, C. A., Klersy, C., Sebastiani, R., Arbustini, E., Recusani, F., & Tavazzi, L. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01102-5 · Cited by 1,285
Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension
Sitbon, O., Humbert, M. J. C., Jaïs, X., Ioos, V., Hamid, A. M., Provencher, S., Garcia, G., Parent, F., Hervé, P., & Simonneau, G. (2005) · Circulation · doi:10.1161/circulationaha.104.488486 · Cited by 1,244
Self-citationSurvival in Primary Pulmonary Hypertension
McLaughlin, V. V., Shillington, A. C., & Rich, S. (2002) · Circulation · doi:10.1161/01.cir.0000029100.82385.58 · Cited by 1,217
Chronic Thromboembolic Pulmonary Hypertension
Hoeper, M. M., Mayer, E., Simonneau, G., & Rubin, L. J. (2006) · Circulation · doi:10.1161/circulationaha.105.602565 · Cited by 1,194
Self-citationInitial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
Galiè, N., Barberà, J. A., Frost, A., Ghofrani, H. A., Hoeper, M. M., McLaughlin, V. V., Peacock, A. J., Simonneau, G., Vachiéry, J., Grünig, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413687 · Cited by 1,182
Self-citationDiagnosis and Assessment of Pulmonary Arterial Hypertension
Badesch, D. B., Champion, H. C., Sánchez, M. Á. G., Hoeper, M. M., Loyd, J. E., Manes, A., McGoon, M. D., Naeije, R., Olschewski, H., Oudiz, R. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.011 · Cited by 1,140
Self-citationExercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
Borlaug, B. A., Nishimura, R. A., Sorajja, P., Lam, C. S. P., & Redfield, M. M. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.930701 · Cited by 1,119
Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Pepke‐Żaba, J., Delcroix, M., Lang, I. M., Mayer, E., Jansa, P., Ambrož, D., Treacy, C., D’Armini, A. M., Morsolini, M., Snijder, R. J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.015008 · Cited by 1,102
Self-citationTadalafil Therapy for Pulmonary Arterial Hypertension
Galiè, N., Brundage, B. H., Ghofrani, H. A., Oudiz, R. J., Simonneau, G., Safdar, Z., Shapiro, S., White, R. J., Chan, M., Beardsworth, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.839274 · Cited by 1,096
Self-citationTricuspid Annular Displacement Predicts Survival in Pulmonary Hypertension
Forfia, P. R., Fisher, M. R., Mathai, S. C., Housten-Harris, T., Hemnes, A. R., Borlaug, B. A., Chamera, E. H., Corretti, M. C., Champion, H. C., Abraham, T. P., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-547oc · Cited by 1,091
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
Galiè, N., Olschewski, H., Oudiz, R. J., Torres, F., Frost, A., Ghofrani, H. A., Badesch, D. B., McGoon, M. D., McLaughlin, V. V., Roecker, E. B., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.742510 · Cited by 1,077
Self-citationAccuracy of Doppler Echocardiography in the Hemodynamic Assessment of Pulmonary Hypertension
Fisher, M. R., Forfia, P. R., Chamera, E. H., Housten-Harris, T., Champion, H. C., Girgis, R. E., Corretti, M. C., & Hassoun, P. M. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200811-1691oc · Cited by 1,075
Badesch, D. B., Tapson, V. F., McGoon, M. D., Brundage, B. H., Rubin, L. J., Wigley, F. M., Rich, S., Barst, R. J., Barrett, P. S., Kral, K. M., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-6-200003210-00002 · Cited by 1,071
Self-citationPrimary pulmonary hypertension: natural history and the importance of thrombosis.
Fuster, V., Steele, P. M., Edwards, W. D., et al. (1984) · Circulation · doi:10.1161/01.cir.70.4.580 · Cited by 1,069
Selexipag for the Treatment of Pulmonary Arterial Hypertension
Sitbon, O., Channick, R. N., Chin, K., Frey, A., Gaine, S., Galiè, N., Ghofrani, H. A., Hoeper, M. M., Lang, I. M., Preiss, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503184 · Cited by 1,062
Self-citationPulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review
Kovács, G., Berghold, A., Scheidl, S. J., & Olschewski, H. (2009) · European Respiratory Journal · doi:10.1183/09031936.00145608 · Cited by 1,053
Chronic thromboembolic pulmonary hypertension
Kim, N. H., Delcroix, M., Jaïs, X., Madani, M. M., Matsubara, H., Mayer, E., Ogo, T., Tapson, V. F., Ghofrani, H. A., & Jenkins, D. P. (2018) · European Respiratory Journal · doi:10.1183/13993003.01915-2018 · Cited by 1,043
Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity
Cottin, V., Nunès, H., Brillet, P., Delaval, P.-E., Devouassoux, G., Tillie‐Leblond, I., Israël‐Biet, D., Court‐Fortune, I., Valeyre, D., & Cordier, J.-F. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00021005 · Cited by 1,013
Diagnosis and differential assessment of pulmonary arterial hypertension
Barst, R. J., McGoon, M. D., Torbicki, A., Sitbon, O., Krowka, M. J., Olschewski, H., & Gaine, S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.032 · Cited by 992
Self-citationIncreased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease?
Stewart, D., Levy, R. D., Černáček, P., & Langleben, D. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-6-464 · Cited by 980
Galiè, N., Rubin, L., Hoeper, M. M., Jansa, P., Al‐Hiti, H., Meyer, G. M. B., Chiossi, E., Kusic‐Pajic, A., & Simonneau, G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60919-8 · Cited by 917
Self-citationEchocardiographic Assessment of Pulmonary Hypertension in Patients with Advanced Lung Disease
Arcasoy, S. M., Christie, J. D., Ferrari, V. A., Sutton, M. S. J., Zisman, D. A., Blumenthal, N. P., Pochettino, A. A., & Kotloff, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1130oc · Cited by 908
(2006) · Springer eBooks · doi:10.1007/3-540-29832-0_1355 · Cited by 885
Diller, G.-P., Dimopoulos, K., Okonko, D., Li, W., Babu-Narayan, S. V., Broberg, C. S., Johansson, B., Bouzas, B., Mullen, M. J., Poole-Wilson, P. A., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.529800 · Cited by 878
Nagaya, N., Nishikimi, T., Uematsu, M., Satoh, T., Kyotani, S., Sakamaki, F., Kakishita, M., Fukushima, K., Okano, Y., Nakanishi, N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.8.865 · Cited by 875
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Lettieri, C. J., Nathan, S. D., Barnett, S. D., Ahmad, S., & Shorr, A. F. (2006) · CHEST Journal · doi:10.1378/chest.129.3.746 · Cited by 873
van de Veerdonk, M. C., Kind, T., Marcus, J. T., Mauritz, G.-J., Heymans, M. W., Bogaard, H.-J., Boonstra, A., Marques, K. M. J., Westerhof, N., & Vonk-Noordegraaf, A. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.068 · Cited by 846
Self-citationBosentan Therapy in Patients With Eisenmenger Syndrome
Galiè, N., Beghetti, M., Gatzoulis, M. Α., Granton, J. T., Berger, R. M. F., Lauer, A., Chiossi, E., & Landzberg, M. J. (2006) · Circulation · doi:10.1161/circulationaha.106.630715 · Cited by 844
Self-citationEvidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
Coghlan, G., Denton, C. P., Grünig, E., Bonderman, D., Distler, O., Khanna, D., Müller‐Ladner, U., Pope, J. E., Vonk, M. C., Doelberg, M., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203301 · Cited by 832
Self-citationEchocardiographic predictors of adverse outcomes in primary pulmonary hypertension
Raymond, R. J., Hinderliter, A. L., Willis, P. W., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01744-8 · Cited by 828
Humbert, M. J. C., Monti, G., Brénot, F., Sitbon, O., Portier, A., Grangeot‐Keros, L., Duroux, P., Galanaud, P., Simonneau, G., & Émilie, D. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.5.7735624 · Cited by 793
Self-citationAn epidemiological study of pulmonary arterial hypertension
Peacock, A., Murphy, N. F., McMurray, J. J. V., Caballero, L., & Stewart, S. (2007) · European Respiratory Journal · doi:10.1183/09031936.00092306 · Cited by 793
Self-citationChronic Thromboembolic Pulmonary Hypertension
Fedullo, P. F., Auger, W. R., Kerr, K. M., & Rubin, L. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmra010902 · Cited by 766
Mukerjee, D., George, D. S., Coleiro, B., Knight, C., Denton, C. P., Davar, J., Black, C. M., & Coghlan, G. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.11.1088 · Cited by 758
Self-citationvan Wolferen, S. A., Marcus, J. T., Boonstra, A., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl477 · Cited by 757
Mayer, E., Jenkins, D. P., Lindner, J., D’Armini, A. M., Kloek, J. J., Meyns, B. P., Ilkjær, L. B., Klepetko, W., Delcroix, M., Lang, I. M., et al. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2010.11.024 · Cited by 747
Self-citationHACHULLA, E., Gressin, V., Guillevin, L., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21433 · Cited by 747
Mereles, D., Ehlken, N., Kreuscher, S., Ghofrani, S., Hoeper, M. M., Halank, M., Meyer, F. J., Karger, G., Buss, J., Juenger, J., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.618397 · Cited by 724
Self-citationSevere Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Chaouat, A., Bugnet, A.-S., Kadaoui, N., Schött, R., Enache, I., Ducoloné, A., Ehrhart, M., Kessler, R., & Weitzenblum, E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-006oc · Cited by 718
Treatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol)
Rubin, L. J., Mendoza, J., Hood, M., McGoon, M., Barst, R., Williams, W. B., Diehl, J. H., Crow, J., & Long, W. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-7-485 · Cited by 701
Pulmonary Hypertension in Chronic Lung Diseases
Seeger, W., Adir, Y., Barberà, J. A., Champion, H. C., Coghlan, G., Cottin, V., Marco, T. D., Galiè, N., Ghio, S., Gibbs, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.036 · Cited by 678
Self-citationSurvival in incident and prevalent cohorts of patients with pulmonary arterial hypertension
Humbert, M. J. C., Sitbon, O., Yaici, A., Montani, D., O’Callaghan, D. S., Jaïs, X., Parent, F., Savale, L., Natali, D., Günther, S., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00057010 · Cited by 675
Self-citationUpdated Treatment Algorithm of Pulmonary Arterial Hypertension
Galiè, N., Corris, P. A., Frost, A., Girgis, R. E., Granton, J. T., Jing, Z., Klepetko, W., McGoon, M. D., McLaughlin, V. V., Preston, I. R., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.031 · Cited by 667
Self-citationPulmonary Arterial Hypertension in Patients Treated by Dasatinib
Montani, D., Bergot, E., Günther, S., Savale, L., Bergeron, A., BOURDIN, A. A., Bouvaist, H., Canuet, M., Pison, C. M., Macro, M., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.079921 · Cited by 658
Self-citationA meta-analysis of randomized controlled trials in pulmonary arterial hypertension
Galiè, N., Mañes, A., Negro, L., Palazzini, M., Reggiani, M. L. B., & Branzi, A. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehp022 · Cited by 648
Self-citationGaliè, N., Humbert, M. J. C., Vachiéry, J., Vizza, C. D., Kneußl, M., Manes, A., Sitbon, O., Torbicki, A., Delcroix, M., Naeije, R., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01786-2 · Cited by 645
Self-citationGenetics and Genomics of Pulmonary Arterial Hypertension
Soubrier, F., Chung, W. K., Machado, R. D., Grünig, E., Aldred, M. A., Geraci, M. W., Loyd, J. E., Elliott, C. G., Trembath, R. C., Newman, J. H., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.035 · Cited by 641
Self-citationCombination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2
Humbert, M. J. C., Barst, R. J., Robbins, I. M., Channick, R. N., Galiè, N., Boonstra, A., Rubin, L. J., Horn, E. M., Manes, A., & Simonneau, G. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00028404 · Cited by 638
Self-citationA Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002110 · Cited by 634
Beraprost therapy for pulmonary arterial hypertension
Barst, R. J., McGoon, M. D., McLaughlin, V. V., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00463-7 · Cited by 632
Pulmonary Hypertension Due to Left Heart Diseases
Vachiéry, J., Adir, Y., Barberà, J. A., Champion, H. C., Coghlan, G., Cottin, V., Marco, T. D., Galiè, N., Ghio, S., Gibbs, J. S. R., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.033 · Cited by 631
Self-citationChristie, J. D., Edwards, L. B., Kucheryavaya, A. Y., Benden, C., Dipchand, A. I., Dobbels, F., Kirk, R., Rahmel, A. O., Stehlik, J., & Hertz, M. I. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.08.004 · Cited by 630
Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension
McLaughlin, V. V., Oudiz, R. J., Frost, A., Tapson, V. F., Murali, S., Channick, R. N., Badesch, D. B., Barst, R. J., Hsu, H. H., & Rubin, L. J. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-358oc · Cited by 624
Exercise Pathophysiology in Patients With Primary Pulmonary Hypertension
Sun, X., Hansen, J. E., Oudiz, R. J., & Wasserman, K. (2001) · Circulation · doi:10.1161/hc2901.093198 · Cited by 624
Madani, M. M., Auger, W. R., Pretorius, V. G., Sakakibara, N., Kerr, K. M., Kim, N. H., Fedullo, P. F., & Jamieson, S. W. (2012) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2012.04.004 · Cited by 616
Simonneau, G., Rubin, L. J., Galiè, N., Barst, R. J., Fleming, T. R., Frost, A. E., Engel, P. J., Kramer, M. R., Burgess, G., Collings, L., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-8-200810210-00004 · Cited by 613
Self-citationHoeper, M. M., Lee, S. H., Voswinckel, R., Palazzini, M., Jaïs, X., Marinelli, A., Barst, R. J., Ghofrani, H. A., Jing, Z., Opitz, C. F., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.061 · Cited by 611
Self-citationMizoguchi, H., Ogawa, A., Munemasa, M., et al. (2012) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.112.971077 · Cited by 609
Krowka, M. J., Plevak, D. J., Findlay, J. Y., Rosen, C. B. B., Wiesner, R. H., & Krom, R. A. F. (2000) · Liver Transplantation · doi:10.1053/jlts.2000.6356 · Cited by 608
Tunariu, N., Gibbs, S., Win, Z. T., Gin‐Sing, W., Graham, A., Gishen, P., & AL-NAHHAS, A. M. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.039438 · Cited by 606
Self-citationSurvival with first-line bosentan in patients with primary pulmonary hypertension
McLaughlin, V. V., Sitbon, O., Badesch, D. B., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00054804 · Cited by 605
Extracorporeal Membrane Oxygenation in Awake Patients as Bridge to Lung Transplantation
Fuehner, T., Kuehn, C., Hadem, J., Wiesner, O., Gottlieb, J., Tudorache, I., Olsson, K. M., Greer, M., Sommer, W., Welte, T., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201109-1599oc · Cited by 596
Self-citationAssessment of Survival in Patients With Primary Pulmonary Hypertension
Wensel, R., Opitz, C. F., Anker, S. D., et al. (2002) · Circulation · doi:10.1161/01.cir.0000022687.18568.2a · Cited by 570
Self-citationAddition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension
McLaughlin, V. V., Benza, R. L., Rubin, L. J., Channick, R. N., Voswinckel, R., Tapson, V. F., Robbins, I. M., Olschewski, H., Rubenfire, M., & Seeger, W. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.027 · Cited by 564
Taylor, D. O., Edwards, L. B., Boucek, M. M., Trulock, E. P., Waltz, D. A., Keck, B. M., & Hertz, M. I. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.05.002 · Cited by 558
Biomarkers and surrogate endpoints in clinical trials
Fleming, T. R., & Powers, J. H. (2012) · Statistics in Medicine · doi:10.1002/sim.5403 · Cited by 555
Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension
Jaïs, X., D’Armini, A. M., Jansa, P., Torbicki, A., Delcroix, M., Ghofrani, H. A., Hoeper, M. M., Lang, I. M., Mayer, E., Pepke‐Żaba, J., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.059 · Cited by 549
Self-citationPediatric Pulmonary Hypertension
Ivy, D. D., Abman, S. H., Barst, R. J., Berger, R. M. F., Bonnet, D., Fleming, T. R., Haworth, S. G., Raj, J. U., Rosenzweig, E. B., Schulze‐Neick, I., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.028 · Cited by 543
Self-citationBalloon Pulmonary Angioplasty for Treatment of Chronic Thromboembolic Pulmonary Hypertension
Feinstein, J. A., Goldhaber, S. Z., Lock, J. E., et al. (2001) · Circulation · doi:10.1161/01.cir.103.1.10 · Cited by 532
Pulmonary Arterial Hypertension
McGoon, M. D., Benza, R. L., Subías, P. E., Jiang, X., Miller, D. P., Peacock, A. J., Pepke‐Żaba, J., Pulido, T., Rich, S., Rosenkranz, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.023 · Cited by 526
Self-citationPulmonary veno-occlusive disease
Montani, D., Lau, E., Dorfmüller, P., Girerd, B., Jaïs, X., Savale, L., Perros, F., Nossent, E. J., Garcia, G., Parent, F., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00026-2016 · Cited by 523
Self-citationAmbrisentan therapy for pulmonary arterial hypertension.
Galiè, N., Badesch, D., Oudiz, R., Simonneau, G., Mcgoon, M., Keogh, A., Frost, A., Zwicke, D., Naeije, R., Shapiro, S., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.050 · Cited by 522
Self-citationEisenmenger syndrome. Factors relating to deterioration and death
Daliento, L., Somerville, J., Presbitero, P., Menti, L., Prever, S. B., Rizzoli, G., & Stone, S. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1046 · Cited by 522
Chronic Thromboembolic Pulmonary Hypertension
Kim, N. H., Delcroix, M., Jenkins, D. P., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.024 · Cited by 520
The endothelin system in pulmonary arterial hypertension
Galiè, N. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.026 · Cited by 517
Self-citationPrognostic Factors in COPD Patients Receiving Long-term Oxygen Therapy
Oswald–Mammosser, M., Weitzenblum, E., Quoix, É., Moser, G., Chaouat, A., Charpentier, C., & Kessler, R. (1995) · CHEST Journal · doi:10.1378/chest.107.5.1193 · Cited by 516
Clinical features of paediatric pulmonary hypertension: a registry study
Berger, R. M. F., Beghetti, M., Humpl, T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61621-8 · Cited by 509
Self-citationLong-Term Prostacyclin for Pulmonary Hypertension With Associated Congenital Heart Defects
Rosenzweig, E. B., Kerstein, D., & Barst, R. J. (1999) · Circulation · doi:10.1161/01.cir.99.14.1858 · Cited by 507
Portopulmonary hypertension and hepatopulmonary syndrome
Hoeper, M. M., Krowka, M. J., & Strassburg, C. P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16107-2 · Cited by 501
Self-citationThabut, G., Dauriat, G., Stern, J. B., Logeart, D., Levy, A., Marrash-Chahla, R., & Mal, H. (2005) · CHEST Journal · doi:10.1378/chest.127.5.1531 · Cited by 494
Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation
Thenappan, T., Shah, S. J., Rich, S., Tian, L., Archer, S. L., & Gomberg‐Maitland, M. (2009) · European Respiratory Journal · doi:10.1183/09031936.00072709 · Cited by 491
Clinical efficacy of sildenafil in primary pulmonary hypertension
Sastry, B. K. S., Narasimhan, C., Reddy, N. K., & Raju, B. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.056 · Cited by 487
Pulmonary Hypertension Due to Left Heart Disease
Guazzi, M., & Borlaug, B. A. (2012) · Circulation · doi:10.1161/circulationaha.111.085761 · Cited by 483
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
Cottin, V., Pavec, J. L., Prévôt, G., Mal, H., Humbert, M. J. C., Simonneau, G., Cordier, J. F., & GERM“O”P (2009) · European Respiratory Journal · doi:10.1183/09031936.00038709 · Cited by 480
Self-citationA Novel Channelopathy in Pulmonary Arterial Hypertension
Ma, L., Roman‐Campos, D., Austin, E. D., Eyries, M., Sampson, K. S., Soubrier, F., Germain, M., Trégouët, D., Borczuk, A., Rosenzweig, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211097 · Cited by 473
Self-citationGoal-oriented treatment and combination therapy for pulmonary arterial hypertension
Hoeper, M. M., Markevych, I., Spiekerkoetter, E. F., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00075305 · Cited by 469
Self-citationWeitzenblum, E., Sautegeau, A., Ehrhart, M., et al. (1985) · American Review of Respiratory Disease · doi:10.1164/arrd.1985.131.4.493 · Cited by 464
Lang, I. M., Pesavento, R., Bonderman, D., & Yuan, J. X. ‐. (2012) · European Respiratory Journal · doi:10.1183/09031936.00049312 · Cited by 461
Self-citationPrevalence of HIV-Related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era
Sitbon, O., Lascoux‐Combe, C., Delfraissy, J., Yéni, P., Raffi, F., de Zuttere, D., Gressin, V., Clerson, P., Séréni, D., & Simonneau, G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200704-541oc · Cited by 457
Self-citationChronic thromboembolic pulmonary hypertension
Dartevelle, P., Fadel, É., Mussot, S., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00079704 · Cited by 451
Fine, N. M., Chen, L., Bastiansen, P. M., Frantz, R. P., Pellikka, P. A., Oh, J. K., & Kane, G. C. (2013) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.113.000640 · Cited by 448
Hopkins, W. E., Ochoa, L. L., Richardson, G., et al. (1996) · PubMed · Cited by 447
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension
Eyries, M., Montani, D., Girerd, B., Perret, C., Leroy, A., Lonjou, C., Chelghoum, N., Coulet, F., Bonnet, D., Dorfmüller, P., et al. (2013) · Nature Genetics · doi:10.1038/ng.2844 · Cited by 445
Self-citationVasodilator Therapy for Primary Pulmonary Hypertension in Children
Barst, R. J., Maislin, G., & Fishman, A. P. (1999) · Circulation · doi:10.1161/01.cir.99.9.1197 · Cited by 429
Fijałkowska, A., Kurzyna, M., Torbicki, A., et al. (2006) · CHEST Journal · doi:10.1378/chest.129.5.1313 · Cited by 416
Self-citationSurvival in pulmonary hypertension in Spain: insights from the Spanish registry
Subías, P. E., Blanco, I., López‐Meseguer, M., López-Guarch, C. J., Román, A., Morales, P., Castillo‐Palma, M. J., Segovia, J., Gómez‐Sánchez, M. Á., & Barberà, J. A. (2012) · European Respiratory Journal · doi:10.1183/09031936.00101211 · Cited by 414
Self-citationPulmonary Vascular Disease in Adults With Congenital Heart Disease
Diller, G., & Gatzoulis, M. A. (2007) · Circulation · doi:10.1161/circulationaha.105.592386 · Cited by 407
Kielstein, J. T., Impraim, B., Simmel, S., Bode‐Böger, S. M., Tsikas, D., Frölich, J. C., Hoeper, M. M., Haller, H. G., & Fliser, D. (2003) · Circulation · doi:10.1161/01.cir.0000105764.22626.b1 · Cited by 400
Self-citationTan, R. T., Kuzo, R. S., Goodman, L. R., et al. (1998) · CHEST Journal · doi:10.1378/chest.113.5.1250 · Cited by 400
Secondary Pulmonary Hypertension in Chronic Heart Failure
Moraes, D. L., Colucci, W. S., & Givertz, M. M. (2000) · Circulation · doi:10.1161/01.cir.102.14.1718 · Cited by 400
Jaïs, X., Launay, D., Yaïci, A., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23303 · Cited by 399
Rubens, C., Ewert, R., Halank, M., et al. (2001) · CHEST Journal · doi:10.1378/chest.120.5.1562 · Cited by 392
Price, L., Wort, S. J., Finney, S. J., Marino, P. S., & Brett, S. J. (2010) · Critical Care · doi:10.1186/cc9264 · Cited by 392
Portopulmonary hypertension: Results from a 10-year screening algorithm
Krowka, M. J., Swanson, K. L., Frantz, R. P., et al. (2006) · Hepatology · doi:10.1002/hep.21431 · Cited by 386
Humbert, M., Yaïci, A., de Groote, P., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30541 · Cited by 382
Self-citationKataoka, M., Inami, T., Hayashida, K., et al. (2012) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.112.971390 · Cited by 382
Engelfriet, P. M., Duffels, M. G. J., Møller, T., Boersma, E. H., Tijssen, J. G. P., Thaulow, E., Gatzoulis, M. A., & Mulder, B. J. M. (2006) · Heart · doi:10.1136/hrt.2006.098848 · Cited by 381
Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study
Sitbon, O., Jaïs, X., Savale, L., Cottin, V., Bergot, E., Macari, E. A., Bouvaist, H., Dauphin, C., Picard, F., Bulifon, S., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00116313 · Cited by 381
Self-citationSurvival in Childhood Pulmonary Arterial Hypertension
Barst, R. J., McGoon, M. D., Elliott, C. G., Foreman, A. J., Miller, D. P., & Ivy, D. D. (2011) · Circulation · doi:10.1161/circulationaha.111.026591 · Cited by 380
Tapson, V. F., Torres, F., Kermeen, F. D., et al. (2012) · CHEST Journal · doi:10.1378/chest.11-2212 · Cited by 378
Anticoagulation and Survival in Pulmonary Arterial Hypertension
Olsson, K. M., Delcroix, M., Ghofrani, H. A., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.004526 · Cited by 373
Barst, R. J., Ivy, D. D., Gaitán, G. A., Szatmári, A., Rudziński, A., García, A. E., Sastry, B. K. S., Pulido, T., Layton, G. R., Serdarevic-Pehar, M., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.016667 · Cited by 371
Antiproliferative Effects of Phosphodiesterase Type 5 Inhibition in Human Pulmonary Artery Cells
Wharton, J., Strange, J., Møller, G. M. O., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200411-1587oc · Cited by 371
Rich, S., Seidlitz, M., Dodin, E., Osimani, D., Judd, D., Genthner, D., McLaughlin, V. V., & Francis, G. S. (1998) · CHEST Journal · doi:10.1378/chest.114.3.787 · Cited by 370
Diastolic Pulmonary Vascular Pressure Gradient
Gerges, C., Gerges, M., Lang, M., Zhang, Y., Jakowitsch, J., Probst, P., Maurer, G., & Lang, I. M. (2013) · CHEST Journal · doi:10.1378/chest.12-1653 · Cited by 369
Self-citationKessler, R., Faller, M., Weitzenblum, E., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.2.2006129 · Cited by 366
Nickel, N. P., Golpon, H. A., Greer, M., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00092311 · Cited by 366
Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension
Montani, D., Savale, L., Natali, D., Jaïs, X., Hervé, P., Garcia, G., Humbert, M. J. C., Simonneau, G., & Sitbon, O. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq170 · Cited by 360
Self-citationGraded balloon dilation atrial septostomy in severe primary pulmonary hypertension
Sandoval, J., Gaspar, J., Pulido, T., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00238-1 · Cited by 356
Pulmonary Veno-Occlusive Disease
Montani, D., Achouh, L., Dorfmüller, P., Pavec, J. L., Sztrymf, B., Tchérakian, C., Rabiller, A., Haque, R. A., Sitbon, O., Jaïs, X., et al. (2008) · Medicine · doi:10.1097/md.0b013e31818193bb · Cited by 356
Self-citationA randomised, controlled trial of bosentan in severe COPD
Stolz, D., Rasch, H., Linka, A., Valentino, M. D., Meyer, A., Brutsche, M. H., & Tamm, M. (2008) · European Respiratory Journal · doi:10.1183/09031936.00011308 · Cited by 355
Barst, R. J. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00005-5 · Cited by 350
Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism
Guérin, L., Couturaud, F., Parent, F., Revel, M., Gillaizeau, F., Planquette, B., Pontal, D., Guégan, M., Simonneau, G., Meyer, G., et al. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-07-0538 · Cited by 349
Self-citationEchocardiographic measurement of the normal adult right ventricle.
Foale, R., Nihoyannopoulos, P., McKenna, W. J., Kleinebenne, A., Nadazdin, A., Rowland, E., Smith, G. S., & Klienebenne, A. (1986) · Heart · doi:10.1136/hrt.56.1.33 · Cited by 349
Self-citationClinical differences between idiopathic and scleroderma‐related pulmonary hypertension
Fisher, M. R., Mathai, S. C., Champion, H. C., Girgis, R. E., Housten-Harris, T., Hummers, L. K., Krishnan, J. A., Wigley, F. M., & Hassoun, P. M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22069 · Cited by 348
Right Ventricular Strain for Prediction of Survival in Patients With Pulmonary Arterial Hypertension
Sachdev, A., Villarraga, H. R., Frantz, R. P., McGoon, M. D., Hsiao, J., Maalouf, J. F., Ammash, N. M., McCully, R. B., Miller, F. A., Pellikka, P. A., et al. (2010) · CHEST Journal · doi:10.1378/chest.10-2015 · Cited by 348
Severe Pulmonary Hypertension during Pregnancy
Bonnin, M., Mercier, F. J., Sitbon, O., et al. (2005) · Anesthesiology · doi:10.1097/00000542-200506000-00012 · Cited by 347
Sugimura, K., Fukumoto, Y., Satoh, K., et al. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-1217 · Cited by 346
Survival in Portopulmonary Hypertension: Mayo Clinic Experience Categorized by Treatment Subgroups
Swanson, K. L., Wiesner, R. H., Nyberg, S. L., Rosen, C. B. B., & Krowka, M. J. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02384.x · Cited by 338
Pediatric Pulmonary Hypertension in the Netherlands
van Loon, R. L. E., Roofthooft, M. T. R., Hillege, H. L., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.969584 · Cited by 330
Avouac, J., AIRÒ, P., Meune, C., Beretta, L., Dieudé, P., Caramaschi, P., TIEV, K. P., Cappelli, S., Diot, É., Vacca, A., et al. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100245 · Cited by 327
Self-citationRiociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction
Bonderman, D., Ghio, S., Felix, S. B., Ghofrani, H. A., Michelakis, E. D., Mitrović, V. L., Oudiz, R. J., Boateng, F., Scalise, A., Roessig, L., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001458 · Cited by 326
Self-citationJing, Z., Parikh, K. H., Pulido, T., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.124388 · Cited by 326
Miller, W. L., Grill, D. E., & Borlaug, B. A. (2013) · JACC Heart Failure · doi:10.1016/j.jchf.2013.05.001 · Cited by 322
Manes, A., Palazzini, M., Leci, E., Reggiani, M. L. B., Branzi, A., & Galiè, N. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht072 · Cited by 322
Self-citationTorbicki, A., Kurzyna, M., Kuca, P., Fijałkowska, A., Sikora, J., Florczyk, M., Pruszczyk, P., Burakowski, J., & Wawrzyńska, L. (2003) · Circulation · doi:10.1161/01.cir.0000084544.54513.e2 · Cited by 317
Self-citationNunès, H., Humbert, M., Sitbon, O., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-330oc · Cited by 317
Self-citationHoeper, M. M., & Granton, J. T. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0662ci · Cited by 316
Self-citationHoeper, M. M., Olschewski, H., Ghofrani, H. A., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00494-5 · Cited by 315
Self-citationSimonneau, G., Torbicki, A., Hoeper, M. M., Delcroix, M., Karlócai, K., Galiè, N., Degano, B., Bonderman, D., Kurzyna, M., Efficace, M., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00137511 · Cited by 313
Self-citationProvencher, S., Hervé, P., Jaïs, X., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.013 · Cited by 312
The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease
Naeije, R., Vachiéry, J., Yerly, P., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00074312 · Cited by 312
Robalino, B. D., & Moodie, D. S. (1991) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80121-4 · Cited by 302
HIV-Associated Primary Pulmonary Hypertension. A Case Control Study. Swiss HIV Cohort Study
Opravil, M., Pechère, M., Speich, R., Joller‐Jemelka, H. I., Jenni, R., Russi, E. W., Hirschel, B. J., & Luthy, R. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.3.9117037 · Cited by 298
Krowka, M. J., Miller, D. P., Barst, R. J., Taichman, D. B., Dweik, R. A., Badesch, D. B., & McGoon, M. D. (2011) · CHEST Journal · doi:10.1378/chest.11-0160 · Cited by 298
Tapson, V. F., Jing, Z., Xu, K., et al. (2013) · CHEST Journal · doi:10.1378/chest.12-2875 · Cited by 298
Pulmonary Veno-occlusive Disease
Mandel, J., Mark, E. J., & Hales, C. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.9912045 · Cited by 296
Pulmonary veno-occlusive disease
Montani, D., Price, L., Dorfmüller, P., Achouh, L., Jaïs, X., Yaici, A., Sitbon, O., Musset, D., Simonneau, G., & Humbert, M. J. C. (2008) · European Respiratory Journal · doi:10.1183/09031936.00090608 · Cited by 296
Self-citationResults of European post-marketing surveillance of bosentan in pulmonary hypertension
Humbert, M. J. C., Segal, E. S., Kiely, D. G., Carlsen, J., Schwierin, B., & Hoeper, M. M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00138706 · Cited by 294
Self-citationSafety and Efficacy of IV Treprostinil for Pulmonary Arterial Hypertension
Tapson, V. F., Gomberg‐Maitland, M., McLaughlin, V. V., Benza, R. L., Widlitz, A. C., Krichman, A. D., & Barst, R. J. (2006) · CHEST Journal · doi:10.1378/chest.129.3.683 · Cited by 293
Treatment Goals of Pulmonary Hypertension
McLaughlin, V. V., Gaine, S., Howard, L., Leuchte, H. H., Mathier, M. A., Mehta, S., Palazzini, M., Park, M., Tapson, V. F., & Sitbon, O. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.034 · Cited by 293
Self-citationLong-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension
Provencher, S., Sitbon, O., Humbert, M. J. C., Cabrol, S., Jaïs, X., & Simonneau, G. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi728 · Cited by 293
Self-citationNagaya, N., Uematsu, M., Satoh, T., et al. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9812078 · Cited by 292
Blanco, I., Gimeno, E., Muñoz, P. A., Pizarro, S., Gistau, C., Rodriguez‐Roisin, R., Roca, J., & Barberà, J. A. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200907-0988oc · Cited by 292
Self-citationKrowka, M. J., Frantz, R. P., McGoon, M. D., Severson, C. J., Plevak, D. J., & Wiesner, R. H. (1999) · Hepatology · doi:10.1002/hep.510300307 · Cited by 291
Thenappan, T., Shah, S. J., Gomberg-Maitland, M., Collander, B., Vallakati, A., Shroff, P., & Rich, S. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.958801 · Cited by 289
Chemokine RANTES in Severe Pulmonary Arterial Hypertension
Dorfmüller, P., Zarka, V., Durand–Gasselin, I., Monti, G., Balabanian, K., Garcia, G., Capron, F., L’Herminé, A. C., Marfaing‐Koka, A., Simonneau, G., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.4.2012112 · Cited by 288
Self-citationGhofrani, H. A., Voswinckel, R., Reichenberger, F., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.060 · Cited by 287
Clinical risk factors for portopulmonary hypertension†
Kawut, S. M., Krowka, M. J., Trotter, J. F., et al. (2008) · Hepatology · doi:10.1002/hep.22275 · Cited by 286
CX3C Chemokine Fractalkine in Pulmonary Arterial Hypertension
Balabanian, K., Foussat, A., Dorfmüller, P., Durand–Gasselin, I., Capel, F., Bouchet‐Delbos, L., Portier, A., Marfaing‐Koka, A., Krzysiek, R., Rimaniol, A., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2106007 · Cited by 286
Self-citationCombining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
Hoeper, M. M., Leuchte, H. H., Halank, M., Wilkens, H., Meyer, F. J., Seyfarth, H.-J., Wensel, R., Ripken, F., Bremer, H., Kluge, S., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00057906 · Cited by 285
Self-citationPaciocco, G., Martínez, F. J., Bossone, E., Pielsticker, E. J., Gillespie, B. W., & Rubenfire, M. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.17406470 · Cited by 282
Pulmonary Pressures and Death in Heart Failure
Bursi, F., McNallan, S. M., Redfield, M. M., Nkomo, V. T., Lam, C. S. P., Weston, S. A., Jiang, R., & Roger, V. L. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.076 · Cited by 280
Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension
Tongers, J., Schwerdtfeger, B., Klein, G. G., Kempf, T., Schaefer, A., Knapp, J.-M., Niehaus, M., Korte, T., & Hoeper, M. M. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.09.008 · Cited by 279
Self-citationInhibition of Hypoxic Pulmonary Vasoconstriction by Nifedipine
Simonneau, G., Escourrou, P., Duroux, P., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198106253042606 · Cited by 275
Self-citationTrulock, E. P., Edwards, L. B., Taylor, D. O., Boucek, M. M., Keck, B. M., & Hertz, M. I. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.06.001 · Cited by 271
Quarck, R. A., Nawrot, T. S., Meyns, B. P., & Delcroix, M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.038 · Cited by 270
Iron Deficiency and Raised Hepcidin in Idiopathic Pulmonary Arterial Hypertension
Rhodes, C. J., Howard, L., Busbridge, M., Ashby, D. R., Kondili, Ε., Gibbs, J. S. R., Wharton, J., & Wilkins, M. R. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.057 · Cited by 269
Barberà, J. A., Roger, N., Roca, J., Rodriguez-Roisín, R., Rovira, I., & Higenbottam, T. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90011-2 · Cited by 269
Self-citation
Research works printed but not linked: 2
- Galiè, 2014, Anticoagulant therapy does not influence long-term outcomes in patients with pulmonary arterial hypertension (PAH): insights from the randomised controlled SERAPHIN trial of macitentan, Eur Heart J, 35, 10
- Galiè, 2013, New treatment strategies for pulmonary arterial hypertension: hopes or hypes, J Am Coll Cardiol, 62, 1101, 10.1016/j.jacc.2013.06.032 · DOI
Cited by
Sorted by citations
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Self-citationHaemodynamic definitions and updated clinical classification of pulmonary hypertension
Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.01913-2018 · Cited by 3,813
Self-citation2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292
Self-citation2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease
Pelliccia, A., Sharma, S., Gati, S., Bäck, M., Börjesson, M., Caselli, S., Collet, J.-P., Corrado, D., Drezner, J. A., Halle, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa605 · Cited by 1,958
Self-citationUpdate of EULAR recommendations for the treatment of systemic sclerosis
Kowal-Bielecka, O., Fransen, J., Avouac, J., Becker, M., Kulak, A., Allanore, Y., Distler, O., Clements, P., Cutolo, M., Czirjak, L., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209909 · Cited by 1,104
Self-citation
Metadata
- Authors
- Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., Ghofrani, A., Gomez Sanchez, M. A., Hansmann, G., Klepetko, W., Lancellotti, P., Matucci, M., McDonagh, T., Pierard, L. A., Trindade, P. T., Zompatori, M., Hoeper, M., ESC Scientific Document Group, Aboyans, V., Vaz Carneiro, A., Achenbach, S., Agewall, S., Allanore, Y., Asteggiano, R., Badano, L. P., Barberá, J. A., Bouvaist, H., Bueno, H., Byrne, R. A., Carerj, S., Castro, G., Erol, Ç., Falk, V., Funck-Brentano, C., Gorenflo, M., Granton, J., Iung, B., Kiely, D. G., Kirchhof, P., Kjellstrom, B., Landmesser, U., Lekakis, J., Lionis, C., Lip, G. Y. H., Orfanos, S. E., Park, M. H., Piepoli, M. F., Ponikowski, P., Revel, M.-P., Rigau, D., Rosenkranz, S., Völler, H., Zamorano, J. L., Zamorano, J. L., Aboyans, V., Achenbach, S., Agewall, S., Badimon, L., Barón-Esquivias, G., Baumgartner, H., Bax, J. J., Bueno, H., Carerj, S., Dean, V., Erol, Ç., Fitzsimons, D., Gaemperli, O., Kirchhof, P., Kolh, P., Lancellotti, P., Lip, G. Y., Nihoyannopoulos, P., Piepoli, M. F., Ponikowski, P., Roffi, M., Torbicki, A., Vaz Carneiro, A., Windecker, S., Myftiu, S., Bonderman, D., Firdovsi, I., Lazareva, I., De Pauw, M., Sokolovic, Š., Velchev, V., Cikeš, M., Moutiris, J. A., Jansa, P., Nielsen-Kudsk, J. E., Anton, L., Jääskeläinen, P., Bauer, F., Chukhrukidze, A., Opitz, C., Giannakoulas, G., Karlócai, K., Oddsson, H., Gaine, S., Menachemi, D., Emdin, M., Sooronbaev, T., Rudzitis, T. A., Gumbiene, L., Lebrun, F., Micallef, J., Botnaru, V., Oukerraj, L., Andreassen, A. K., Kurzyna, M., Leite Baptista, M. J. R., Coman, I. M., Moiseeva, O., Stefanovic, B. S., Šimková, I., Wikström, G., Schwerzmann, M., Srbinovska-Kostovska, E., van Dijk, A. P. J., Mahdhaoui, A., Kaymaz, C., Coghlan, G., & Sirenko, Y.
- Affiliations
- University of Bologna (IT)
- Université Paris-Sud (FR)
- ORCID
- Galiè, Nazzareno
- Humbert, Marc
- Lang, Irene
- Simonneau, Gérald
- Beghetti, Maurice
- Hansmann, Georg
- Klepetko, Walter
- Trindade, Pedro T.
- Hoeper, Marius
- Asteggiano, Riccardo
- Badano, Luigi Paolo
- Falk, Volkmar
- Iung, Bernard
- Kiely, David G
- Landmesser, Ulf
- Lionis, Christos
- Park, Myung H
- Revel, Marie-Pierre
- Bax, Jeroen J
- Kolh, Philippe
- Windecker, Stephan
- Giannakoulas, George
- Botnaru, Victor
- Kurzyna, Marcin
- Šimková, Iveta
- Coghlan, Gerry
- Sirenko, Yuriy
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-08-29
- Volume
- 37
- Issue
- 1
- Pages
- 67-119
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2161370807
- Cited by
- 6,931
- References
- 471
- Citations by year
- 2026: 174 · 2025: 297 · 2024: 408 · 2023: 560 · 2022: 778 · 2021: 953 · 2020: 930 · 2019: 794 · 2018: 801 · 2017: 659 · 2016: 461 · 2015: 65
- FWCI
- 524.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Open Repository and Bibliography (University of Liège) (submittedVersion, other-oa)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- IRIS (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- European Respiratory Society
- European Society of Cardiology
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Congenital Heart Disease Studies
- Keywords
- pulmonary hypertension, diagnosis, treatment, right ventricular function, pulmonary circulation, congenital heart disease, valvular heart disease, heart failure, pharmacotherapy, cardiovascular surgery
- MeSH terms
- Adult, Algorithms, Antihypertensive Agents, Arrhythmias, Cardiac, Child, Combined Modality Therapy, Connective Tissue Diseases, Cross Infection, Drug Interactions, Echocardiography, Electrocardiography, Exercise Test, Exercise Therapy, Female, Genetic Counseling, Genetic Testing, Health Status, Cardiac Catheterization, Heart Defects, Congenital, Hemangioma, Hemoptysis, Humans, Hypertension, Portal, Hypertension, Pulmonary, Patient Compliance, Pregnancy, Pregnancy Complications, Cardiovascular, Referral and Consultation, Respiratory Function Tests, Risk Factors, Social Support, Terminal Care, Thromboembolism, Tomography, X-Ray Computed, Biomarkers, HIV Infections, Lung Transplantation, Treatment Outcome, Elective Surgical Procedures, Ventricular Dysfunction, Right, Risk Assessment, Magnetic Resonance Angiography, Therapies, Investigational, Travel Medicine, Balloon Embolectomy, Multimodal Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
